跳至主要内容
临床试验/NCT02293642
NCT02293642已完成不适用

Prospective Epidemiology Study to Validate the BOMET-QoL-10 in Patients With Bone Metastasis in Germany

iOMEDICO AG1 个研究点 分布在 1 个国家目标入组 370 人开始时间: 2014年12月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
iOMEDICO AG
入组人数
370
试验地点
1
主要终点
QoL

研究概览

简要总结

Translation and validation of the BOMET-QoL-10 questionnaire in Germany and assessment of its validity and responsiveness.

详细描述

Aim of this study is to translate the questionnaire and to examine the psychometric properties of BOMET-QoL-10 in a German population. Correlations with the EORTC QLQ-C30/BM22 at the time of enrolment and throughout the study aim to verify that the BOMET-QoL-10 is reliable, valid and able to detect stabilization or changes in quality of life.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Male or female adults patients (≥ 18 years)
  • Diagnosed cancer of the breast, kidney, lung or prostate
  • Bone metastases
  • Estimated life expectancy of at least 6 months
  • Fluent German speaking, reading and writing
  • Informed written consent

排除标准

  • Patients without bone metastases
  • Participation in another study involving questionnaires
  • Patients not able to comply with the assessments specified in the protocol

结局指标

主要结局

QoL

时间窗: 6 months

Validity and responsiveness of the BOMET-QoL-10 questionnaire in reference to EORTC QLQ-C30/BM-22

次要结局

  • Impact of characteristics on questionnaire scores(6 months)
  • Sensitivity of questionnaire(6 months)
  • Sequence effects of questionnaires(6 months)

研究者

发起方
iOMEDICO AG
申办方类型
Industry
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验